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Abstract
Background: Hematoma formation around the knee is commonly seen after total knee arthroplasty (TKA) and may
cause patient discomfort and worry regarding the success of the surgery. This study aimed to evaluate the coagulation
functions and hemorheological parameters in patients undergoing TKA and investigate their associations with hematoma
formation.
Methods: This study prospectively included 146 patients treated for knee osteoarthritis by unilateral TKA between August
2013 and August 2014. Apixaban was administered twice during the 12–24-h period after surgery. Blood coagulation
functions were evaluated according to activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin
time, and fibrinogen preoperatively and on postoperative days 1, 3, 7, and 14. Hemorheological parameters were also
measured. Patients were divided into a hematoma group and a non-hematoma group for comparison.
Results: On postoperative day 1, the hematoma group showed significantly prolonged APTT and PT and significantly
decreased hematocrit relative to baseline values (P < 0.05). The whole blood high shear rate, whole blood low shear rate,
plasma viscosity, and hematocrit did not differ significantly between the two groups at baseline or from postoperative
days 1–14 in (P > 0.05).
Conclusions: Prolonged APTT and PT on the first day after TKA as well as decreased hematocrit may indicate an
increased risk of hematoma formation. Postoperative use of apixaban may promote the formation of ecchymoses but is
not a major contributing factor.
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Background
Total knee arthroplasty (TKA) is an effective treatment
for advanced pathological conditions of the knee. TKA
is performed increasingly often due to the global aging
trend. However, this procedure is associated with some
complications. Patients undergoing TKA are often at a
hypercoagulable state and prone to the development of
thrombosis. If not properly managed, the incidence of
venous thromboembolism (VTE) in these patients can
be as high as 40–80 %, resulting in a mortality rate of
2 % due to symptomatic pulmonary embolism [1, 2].
The American Academy of Orthopaedic Surgeons and
the American College of Chest Physicians developed
new evidence-based guidelines for VTE prophylaxis after
total joint arthroplasty in 2013. According to the up-
dated guidelines, one of the following agents should be
used for a minimum of 14 days after surgery: warfarin,
low-molecular-weight heparin, fondaparinux, aspirin,
rivaroxaban, dabigatran, apixaban, or portable mechan-
ical compression. Moreover, bleeding tendencies in these
patients must be monitored carefully [2]. Although these
prophylaxis treatments very rarely cause major hemor-
rhaging, their use during the first 2 weeks after TKA
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more commonly contributes to the occurrence of ecchym-
oses and limb swelling, complications that may cause
worry among patients and delay the initiation of exercise,
leading to compromised clinical outcomes [3, 4].
Many factors have been proposed to be related to
hematoma formation after TKA, such as the concurrent
use of continuous femoral nerve block and an anticoagu-
lant [3], postoperative drainage patterns [4–7], tourniquet
use during operation [8, 9], postoperative anticoagulant use
[10], and postoperative lower limb positioning [11, 12].
However, the specific underlying reasons for hematoma
formation after TKA remain unclear. We hypothesized
that hypercoagulability and hemorheological changes are
involved in the development of ecchymoses after TKA. To
test this hypothesis, in this study, we evaluated the coagula-
tion functions and hemorheological parameters during the
perioperative period of TKA and analyzed potential associ-
ations with hematoma formation.
Methods
Patients
This study included 146 patients with knee osteoarthritis
who were treated between August 2013 and August
2014 at our hospital. The patients included 51 males and
95 females and had a mean age of 70 years (range, 64–
78 years). Osteoarthritis was diagnosed according to the
criteria provided by the American College of Rheumatol-
ogy in 1995 [13]. Only patients with surgical indications
for TKA were included in this study. The surgical indi-
cations for TKA were several instability, pain, deformity,
and dysfunction of the knee joint. All patients under-
went unilateral TKA. Exclusion criteria were the patients
with end-stage renal disease, severe liver dysfunction,
major comorbidities (bleeding disorders, ischemic heart
disease, and peripheral vascular diseases), and any kind
of cancer disease. Informed written consent was ob-
tained from all patients, and the study was approved by
the Ethics Committee of the First Affiliated Hospital,
Jinan University.
Postoperative management
Drainage tubes were placed postoperatively and removed
within 24–48 h. The tubes were not temporarily clipped
after TKA. Antibiotics were used for 3 days to prevent
infection. Patients were instructed to wear elastic stock-
ings. Apixaban at a dose of 2.5 mg was administered
twice during the 12–24-h period postoperatively. Pa-
tients were encouraged to initiate exercise from the first
day after surgery as a prophylaxis measure for deep vein
thrombosis. Patients were closely monitored to record
the occurrence of hematoma and divided into a
hematoma group and a non-hematoma group. All pa-
tients were followed up for at least 2 months, and no
cases of symptomatic VTE were observed.
Blood measurements
Peripheral blood was collected from each patient pre-
operatively and on postoperative days 1, 3, 7, and 14 for
blood measurements. Blood coagulation functions were
evaluated based on activated partial thromboplastin time
(APTT), prothrombin time (PT), thrombin time (TT),
and fibrinogen (FIB) using an automated blood coagula-
tion analyzer (STAGO, France). Hemorheological pa-
rameters were measured using a hemorheological
analyzer (LBY-N6C, Puli Inc., Beijing, China).
Statistical analysis
Continuous data are presented as mean ± standard devi-
ation values and were compared using Student t tests or
one-way analysis of variance. Categorical data are pre-
sented as frequencies or percentages and were compared
using χ2 tests. All statistical analyses were performed using
SPSS 16.0 software for Windows (SPSS Inc., Chicago, IL,
USA). P < 0.05 was considered statistically significant.
Results
Patient information
No significant differences were found in terms of sex,
age, body mass index (BMI), and presence of diabetes or
hypertension between patients in the hematoma group
(n = 32) and those in the non-hematoma group (n = 114;
Table 1). However, a significantly higher percentage of
patients in the hematoma group had joint deformity
(100 vs. 66.7 %, P < 0.001), and accordingly, the oper-
ation time was significantly longer for these patients
(83.9 ± 3.1 vs. 70.5 ± 4.2 min, P < 0.001) than for patients
in the non-hematoma group.
Comparison of coagulation functions
No significant differences were observed in APTT,
PT, TT, and FIB between patients in the hematoma
and non-hematoma groups preoperatively (P > 0.05).
In comparison to preoperative values, APTT was sig-
nificantly increased in the hematoma group on post-
operative days 1, 3, and 7 and in the non-hematoma
group on postoperative days 3 and 7 (P < 0.05, Fig. 1).
In addition, the hematoma group showed a signifi-
cantly higher APTT than the non-hematoma group
on postoperative days 1, 3, and 7 (P < 0.05). Also, in
comparison to preoperative values, PT was signifi-
cantly increased in the hematoma group on postoper-
ative days 1, 3, 7, and 14 (P < 0.05) but not in the
non-hematoma group. In addition, FIB was signifi-
cantly increased in the non-hematoma group on post-
operative days 3, 7, and 14 but only on postoperative
day 7 in the hematoma group (P < 0.05).
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Comparison of hemorheological parameters
The whole blood high shear rates, whole blood low
shear rates, plasma viscosities, and hematocrit levels
did not differ significantly between the hematoma
and non-hematoma groups at baseline or from post-
operative days 1–14 (P > 0.05). However, the
hematocrit level was significantly decreased on post-
operative days 1, 3, and 7 in the hematoma group
compared with the baseline value (P < 0.05, Fig. 2).
Discussion
The specific mechanisms underlying the formation of
ecchymoses after TKA remain unclear. However, our
study showed that patients who experienced ecchymoses
had significantly prolonged APTTs and PTs as well as
significantly decreased hematocrit levels after TKA in
comparison with baseline values. These findings may
help clinicians identify patients at increased risk for
hematoma formation after TKA.
In our study, preoperative coagulation functions did
not differ significantly between patients with and with-
out postoperative hematoma. Therefore, we are unable
to predict the occurrence of hematoma based on pre-
operative coagulation functions. However, among pa-
tients with a hematoma, APTT was significantly
prolonged to beyond 10 s on postoperative day 1 in
comparison with baseline data. On the contrary, APTT
in the non-hematoma group on postoperative day 1 was
not significantly different from the baseline value. These
results suggest that a prolonged APTT on postoperative
day 1 may be predictive of hematoma formation. In
addition, blood tests were performed on postoperative
day 1 before the administration of apixaban. Therefore,
the prolonged APTT was not caused by apixaban.
Table 1 Comparison of baseline data between patients in the
hematoma group and the non-hematoma group
Hematoma
group (n = 32)
Non-hematoma
group (n = 114)
P value
Sex (male/female) 11/21 40/74 0.94
Age (years) 70.6 ± 4.1 70.9 ± 4.7 0.932
Diabetes, n (%) 12 (37.5 %) 28 (24.6 %) 0.147
Hypertension, n (%) 25 (78.1 %) 71 (62.3 %) 0.095
BMI (kg/m2) 25 ± 2.2 26 ± 2.4 0.061
Joint deformity, n (%) 32 (100 %) 76 (66.7 %) <0.001
Operation time (min) 83.9 ± 3.1 70.5 ± 4.2 <0.001
Fig. 1 Changes in APTT, PT, TT, and FIB in the hematoma group and the non-hematoma group. Triangle P < 0.05 vs. preoperative values, asterisk
P < 0.05 vs. the other group at the same time point
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Similar patterns were also observed for PT, which was
significantly prolonged during the postoperative period
in the hematoma group but not in the non-hematoma
group. Thus, our results indicate that, together, pro-
longed APTT and PT on postoperative day 1 can be
used to predict hematoma formation after TKA.
Hemorheological parameters reflect the properties of
blood flow, with increased hemorheological parameters
indicating higher blood viscosity and greater risks of
thrombosis formation [14]. Blood viscosity is determined
by both the whole blood viscosity and plasma viscosity.
An increase in whole blood viscosity with a high shear rate
can lead to decreased erythrocyte deformability, whereas
an increase in whole blood viscosity with a low shear rate
can lead to increased erythrocyte aggregation [15]. Our
study found that the whole blood high shear rate, whole
blood low shear rate, plasma viscosity, and hematocrit
level did not differ significantly between patients in the
hematoma and non-hematoma groups at baseline and
from postoperative days 1–14. These results suggest that
the erythrocyte deformability and aggregation were not
significantly altered by the TKA procedure. We speculate
that the use of apixaban helped to maintain the blood
viscosity in the patients included in this study. A de-
creased hematocrit level is a sign of anemia or hemodilu-
tion [16], and in our study, hematocrit levels were
significantly decreased in the hematoma group on postop-
erative days 1, 3, and 7 compared to the baseline value. In
contrast, hematocrit levels in the non-hematoma group
did not change significantly. We speculate that the
hematoma group had a higher incidence of hemodilution,
leading to decreased levels of coagulant factors and in-
creased bleeding risk.
Conclusions
In conclusion, prolonged APTT and PT on the first day
after TKA together with a decreased hematocrit level may
indicate an increased risk of hematoma formation. Postop-
erative use of apixaban may promote the formation of ec-
chymoses but is not a major contributing factor. Infusion of
plasma or coagulant factors might be an effective prophy-
laxis measure to prevent hematoma formation after TKA.
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